Sangamo Therapeutics, Inc.

Direct answer

Sangamo Therapeutics, Inc. is publicly traded on OTC under the ticker SGMO.

Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; small fiber neuropathy for...

Can you invest in Sangamo Therapeutics, Inc.?

Yes. Sangamo Therapeutics, Inc. is publicly traded on OTC under the ticker SGMO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Sangamo Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.